Deka Biosciences
PrivateCompany Overview
Deka Biosciences is a biotechnology company that develops targeted cytokine therapies for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
cytokine therapyprecision medicinebiotechfusion proteinsimmunotherapydrug discoverydrug delivery systemclinical-stage biotechbiomarkercompanion diagnosticsolid tumor treatmenttargeted therapynext-gen biologicsprotein engineeringautoimmune disease treatment
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deka Biosciences Comparables
Compare Deka Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 88% | |
| Bright Peak Therapeutics | 88% | |
| Asher Biotherapeutics | 86% | |
Deka Biosciences Funding Rounds
Historical fundraising activity
Deka Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Deka Biosciences's valuation, stock price, and market status.
See something wrong or outdated?